ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 5
| Issue : 4 | Page : 94-99 |
|
Clinical characterization of consecutive patients treated with endovenous radiofrequency ablation of the great saphenous vein in Northwest China
Yongfeng Zhao1, Qian Yang2, Xiaoyu Zhao1, Zilong Dong1, Xi Chen1, Zhen Liu1, Peng Tang3, Hui Xu1, Yung-Wei Chi4, Liwen Liu1
1 Department of Ultrasound, Xijing Hospital of the Air Force Medical University, Xi'an, China 2 Department of Ultrasound, The First Medical Center of Chinese PLA General Hospital, Beijing, China 3 Department of Orthopedics and Rehabilitation, China Rehabilitation Research Center, Beijing Charity Hospital, Beijing, China 4 University of California, Davis, Vascular Center, Sacramento, CA, USA
Correspondence Address:
Dr. Liwen Liu Department of Ultrasound, Xijing Hospital, Air Force Medical University, Xi'an China
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/2589-9686.376921
|
|
INTRODUCTION: The goal of this study was to characterize consecutive patients in Northwest China treated with endovenous radiofrequency ablation (RFA) and foam sclerotherapy over a 10-month period in 2020.
METHODS: A total of 55 (31 men) patients were analyzed. An ultrasound examination was performed preprocedure and at set intervals up to 6 months postprocedure. The clinical-etiological-anatomical-pathophysiological classification, Venous Clinical Severity Score (VCSS), and heaviness, achiness, swelling, throbbing, and itching (HASTI) score were used.
RESULTS: Ultrasound confirmed 23 (41.8%) patients had unilateral disease and 32 (58.2%) had bilateral disease. Of the total 87 limbs, C2 predominated (42;48.3%). At 6 months postprocedure, VCSS improved in the C2, C4, C5, and C6 classes (P < 0.001); HASTI improved in the C2, C3, C4, and C5 classes (P < 0.001).
CONCLUSION: This is one of the few clinical characterizations of patients who had RFA and foam sclerotherapy in Northwest China. Overall, both the VCSS and the HASTI score demonstrated improvement postintervention.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|